The Propantheline Bromide Tablets, cataloged under National Stock Number 6505-01-044-8073, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. Government technical data includes 5 specifications, cited from the U.S. Government catalog. 1 additional reference document (drawings, advisory and superseded references) is recorded in the U.S. Government catalog. Current acquisition status: Active.
| Parameter | Value |
|---|---|
| NSN | 6505-01-044-8073 |
| Item Name | Propantheline Bromide Tablets |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Status | ACTIVE |
| Administration | ORAL |
| Primary Container Content Quantity | 10.000 TABLETS |
| Medical Designation and Grade | UNITED STATES PHARMACOPEIA |
| Primary Container Type | STRIP |
| Total Primary Container Quantity | 10 |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Reference | Meaning |
|---|---|
| NDC00054-8737-25 | 3/9 Design control — primary reference Boehringer Ingelheim Roxane, Inc. Div Sub of Boehringer Ingelheim Corp |
NSN 6505-01-044-8073 is a Propantheline Bromide Tablets, classified under FSC 6505, Drugs and Biologicals. Status: active.
Key specifications for 6505-01-044-8073: Administration: ORAL; Primary Container Content Quantity: 10.000 TABLETS; Medical Designation and Grade: UNITED STATES PHARMACOPEIA; Primary Container Type: STRIP. 5 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.